908 Devices Inc. today announced it will participate in the following investor conferences.
BOSTON--(BUSINESS WIRE)-- 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the following investor conferences.
- 2024 Leerink Partners Healthcare Crossroads Conference, Austin, Texas
Fireside chat on Wednesday, May 29 at 8:00 a.m. Central Time / 9:00 a.m. Eastern Time
- William Blair 44th Annual Growth Stock Conference, Chicago, Illinois
Presentation on Tuesday, June 4 at 10:40 a.m. Central Time / 11:40 a.m. Eastern Time
Interested parties may access a live and archived webcast of these sessions on the “Investors” section of the company website at: www.908devices.com.
About 908 Devices
908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma/biopharma, forensics and adjacent markets. The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic sampling and separations, software automation, and machine learning.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240515771040/en/
Source: 908 Devices Inc.
View this news release online at:
http://www.businesswire.com/news/home/20240515771040/en
